<DOC>
	<DOCNO>NCT00617864</DOCNO>
	<brief_summary>This research study design look effect human albumin transfusion circulating level Vascular Endothelial Derived Growth Factor ( VEGF ) , protein believe responsible syndrome ovarian hyperstimulation . Patients ask participate identify risk Ovarian Hyperstimulation Syndrome ( OHSS ) , potentially serious complication vitro fertilization . It establish onset OHSS may preventable infusion albumin time egg retrieval ; however , know mechanism albumin work . As know pathogenesis OHSS relate VEGF release ovary , believe human albumin may serve `` bind '' VEGF prevent cause harmful effect . The purpose study evaluate effect albumin infusion blood urine VEGF level patient .</brief_summary>
	<brief_title>The Effect Human Albumin Infusion VEGF Levels Women Risk Ovarian Hyperstimulation Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Ovarian Hyperstimulation Syndrome</mesh_term>
	<criteria>Infertile patient undergo vitro fertilization without ICSI Estradiol &gt; 3000 pg/mL time hCG administration &gt; /= 20 follicle see ultrasound monitoring Patients polycystic ovarian syndrome Patients one ovary Patients medical contraindication human albumin ( hypersensitivity , hypervolemia , cardiac insufficiency , hypertension , esophageal varix , pulmonary edema , severe anemia , renal failure )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>42 Years</maximum_age>
	<verification_date>February 2012</verification_date>
</DOC>